Braxia Scientific

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2002, Braxia Scientific has already paid €1.45 in dividends. The last payout was in August 2002.

Financials

In the last year, Braxia Scientific had revenue of €1.28m and net profit of -€8.94m

(EUR)	2023	YoY
Revenue	1.28m	19.25%
Gross profit	116.8k	104.93%
Net profit	-8.94m	1.94%
EBITDA	-8.64m	68.13%

Fundamentals

Metric	Value
Market capitalization	€25.37k
Number of shares	283.28m
52-week high/low	€0.00115 - €0.0000896
Dividends	No
Beta	1.36
P/E ratio	-0.09
PEG ratio	0.00
P/B ratio	0.71
P/S ratio	0.75

Company profile

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.